This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

	
Amend CSHB 2292 as follows:                                                  
	SECTION 2.12.  On page 70, line 11, after "Section 531.072" 
strike "except for any drug exempted from prior authorization 
requirements by federal law" and substitute "except:
		(1)  the Commission shall impose no requirements for 
prior authorizations or other restrictions on medications used to 
treat mental illness such as schizophrenia, depression or bipolar 
disorder until 30 days after it has conducted a study of the impact 
of such requirements on the quality of patient care for the program 
that uses drugs for mental illness and any increase in cost in other 
parts of the state's budget, including hospital costs, physician 
costs and criminal justice cost, and only if the study results 
conclude that such requirements do not pose a significant negative 
impact on the health or quality of life of persons with mental 
illness.  The report by the Commission shall be submitted to the 
Governor, Lt. Governor and Speaker of the House; and
		(2)  for any drug exempted from prior authorization 
requirements by federal law."